Annotation (Toggle Detail/Summary View) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gene-Chemical Interaction Annotations
Gene-Chemical Interaction AnnotationsTerm | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane | multiple interactions | ISO | RGD:2435 | 6480464 | 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the reaction [FSHB protein affects the expression of CSTB mRNA]; more ... | CTD | PMID:19414516 | 17alpha-ethynylestradiol | increases expression | ISO | RGD:10417 | 6480464 | Ethinyl Estradiol results in increased expression of CSTB mRNA | CTD | PMID:17942748 PMID:16174780 | 17alpha-ethynylestradiol | increases expression | ISO | RGD:10417 | 6480464 | Ethinyl Estradiol results in increased expression of CSTB mRNA | CTD | PMID:16174780 PMID:17942748 | 17alpha-ethynylestradiol | decreases expression | ISO | RGD:2435 | 6480464 | Ethinyl Estradiol results in decreased expression of CSTB mRNA | CTD | PMID:16174780 | 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:10417 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CSTB mRNA | CTD | PMID:17942748 | 17alpha-ethynylestradiol | affects expression | ISO | RGD:10417 | 6480464 | Ethinyl Estradiol affects the expression of CSTB mRNA | CTD | PMID:17555576 | 17beta-estradiol | increases expression | ISO | RGD:10417 | 6480464 | Estradiol results in increased expression of CSTB mRNA | CTD | PMID:14664709 PMID:15289156 | 17beta-estradiol | increases expression | ISO | RGD:10417 | 6480464 | Estradiol results in increased expression of CSTB mRNA | CTD | PMID:15289156 PMID:14664709 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:10417 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CSTB mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:10417 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CSTB mRNA | CTD | PMID:19465110 | 2,6-dinitrotoluene | affects expression | ISO | RGD:2435 | 6480464 | 2,6-dinitrotoluene affects the expression of CSTB mRNA | CTD | PMID:21346803 | 2-nitrofluorene | increases expression | ISO | RGD:2435 | 6480464 | 2-nitrofluorene results in increased expression of CSTB mRNA | CTD | PMID:15890375 | 3',5'-cyclic AMP | multiple interactions | ISO | RGD:2435 | 6480464 | 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the reaction [Cyclic AMP affects the expression of CSTB mRNA] | CTD | PMID:19414516 | 3H-1,2-dithiole-3-thione | decreases expression | ISO | RGD:2435 | 6480464 | 1,2-dithiol-3-thione results in decreased expression of CSTB mRNA | CTD | PMID:19162173 | 4,4'-diaminodiphenylmethane | decreases expression | ISO | RGD:10417 | 6480464 | 4,4'-diaminodiphenylmethane results in decreased expression of CSTB mRNA | CTD | PMID:18648102 | 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | increases expression | ISO | RGD:2435 | 6480464 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CSTB mRNA | CTD | PMID:15890375 | aflatoxin B1 | increases expression | ISO | RGD:2435 | 6480464 | Aflatoxin B1 results in increased expression of CSTB mRNA | CTD | PMID:15890375 | ammonium chloride | affects expression | ISO | RGD:2435 | 6480464 | Ammonium Chloride affects the expression of CSTB mRNA | CTD | PMID:16483693 | atrazine | multiple interactions | EXP | | 6480464 | [Atrazine co-treated with Arsenates] results in increased expression of CSTB mRNA | CTD | PMID:18585445 | benzo[a]pyrene | multiple interactions | ISO | RGD:10417 | 6480464 | AHR protein affects the reaction [Benzo(a)pyrene affects the expression of CSTB mRNA] | CTD | PMID:22228805 | benzo[a]pyrene | increases expression | ISO | RGD:10417 | 6480464 | Benzo(a)pyrene results in increased expression of CSTB mRNA | CTD | PMID:22228805 | cadmium dichloride | decreases methylation | ISO | RGD:2435 | 6480464 | Cadmium Chloride results in decreased methylation of CSTB promoter | CTD | PMID:22457795 | choline | multiple interactions | ISO | RGD:10417 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CSTB mRNA | CTD | PMID:20938992 | ciglitazone | multiple interactions | EXP | | 6480464 | [ciglitazone binds to PPARG protein alternative form] which results in increased expression of CSTB mRNA | CTD | PMID:16197558 | copper(2+) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of CSTB mRNA | CTD | PMID:19549813 | copper(II) chloride | affects binding | EXP | | 6480464 | CSTB protein binds to cupric chloride | CTD | PMID:16939620 | Delta(9)-tetrahydrocannabinol | increases expression | EXP | | 6480464 | Tetrahydrocannabinol results in increased expression of CSTB protein; more ... | CTD | PMID:18163980 | diarsenic trioxide | decreases expression | EXP | | 6480464 | arsenic trioxide results in decreased expression of CSTB protein | CTD | PMID:19364129 | diethylstilbestrol | increases expression | ISO | RGD:10417 | 6480464 | Diethylstilbestrol results in increased expression of CSTB mRNA | CTD | PMID:15289156 | diethylstilbestrol | increases expression | ISO | RGD:2435 | 6480464 | Diethylstilbestrol results in increased expression of CSTB mRNA | CTD | PMID:15890375 | folic acid | multiple interactions | ISO | RGD:10417 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CSTB mRNA | CTD | PMID:20938992 | fumonisin B1 | increases expression | ISO | RGD:10417 | 6480464 | fumonisin B1 results in increased expression of CSTB mRNA | CTD | PMID:16221962 | genistein | increases expression | ISO | RGD:10417 | 6480464 | Genistein results in increased expression of CSTB mRNA | CTD | PMID:15289156 | griseofulvin | increases expression | ISO | RGD:10417 | 6480464 | Griseofulvin results in increased expression of CSTB mRNA | CTD | PMID:12735108 | isotretinoin | decreases expression | EXP | | 6480464 | Isotretinoin results in decreased expression of CSTB mRNA | CTD | PMID:20436886 | L-methionine | multiple interactions | ISO | RGD:10417 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CSTB mRNA | CTD | PMID:20938992 | methamphetamine | affects expression | ISO | RGD:2435 | 6480464 | Methamphetamine affects the expression of CSTB protein | CTD | PMID:17904249 | methapyrilene | increases expression | ISO | RGD:2435 | 6480464 | Methapyrilene results in increased expression of CSTB mRNA | CTD | PMID:15890375 | microcystin-LR | increases expression | ISO | RGD:10417 | 6480464 | cyanoginosin LR results in increased expression of CSTB mRNA | CTD | PMID:17654400 | morphine | decreases expression | ISO | RGD:2435 | 6480464 | Morphine results in decreased expression of CSTB protein | CTD | PMID:23056601 | N-nitrosodimethylamine | increases expression | ISO | RGD:2435 | 6480464 | Dimethylnitrosamine results in increased expression of CSTB mRNA | CTD | PMID:15890375 | nickel atom | increases expression | ISO | RGD:10417 | 6480464 | Nickel results in increased expression of CSTB mRNA | CTD | PMID:12540486 | paracetamol | affects expression | ISO | RGD:10417 | 6480464 | Acetaminophen affects the expression of CSTB mRNA | CTD | PMID:17562736 | phenobarbital | multiple interactions | ISO | RGD:10417 | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of CSTB mRNA] | CTD | PMID:19482888 | phenobarbital | increases expression | ISO | RGD:10417 | 6480464 | Phenobarbital results in increased expression of CSTB mRNA | CTD | PMID:19482888 | phosgene | affects expression | ISO | RGD:10417 | 6480464 | Phosgene affects the expression of CSTB mRNA | CTD | PMID:16300373 | piperonyl butoxide | increases expression | ISO | RGD:2435 | 6480464 | Piperonyl Butoxide results in increased expression of CSTB mRNA | CTD | PMID:15890375 | pirinixic acid | decreases expression | ISO | RGD:2435 | 6480464 | pirinixic acid results in decreased expression of CSTB mRNA | CTD | PMID:19162173 | pirinixic acid | increases expression | ISO | RGD:10417 | 6480464 | pirinixic acid results in increased expression of CSTB mRNA | CTD | PMID:18301758 PMID:16221962 | pirinixic acid | increases expression | ISO | RGD:10417 | 6480464 | pirinixic acid results in increased expression of CSTB mRNA | CTD | PMID:16221962 PMID:18301758 | pirinixic acid | increases expression | ISO | RGD:2435 | 6480464 | pirinixic acid results in increased expression of CSTB mRNA | CTD | PMID:15890375 | pregnenolone 16alpha-carbonitrile | decreases expression | ISO | RGD:2435 | 6480464 | Pregnenolone Carbonitrile results in decreased expression of CSTB mRNA | CTD | PMID:19162173 | propiconazole | increases expression | ISO | RGD:10417 | 6480464 | propiconazole results in increased expression of CSTB mRNA | CTD | PMID:21278054 | tamoxifen | affects expression | EXP | | 6480464 | Tamoxifen affects the expression of CSTB mRNA | CTD | PMID:14699072 | tamoxifen | affects expression | ISO | RGD:10417 | 6480464 | Tamoxifen affects the expression of CSTB mRNA | CTD | PMID:17555576 | vancomycin | decreases expression | ISO | RGD:10417 | 6480464 | Vancomycin results in decreased expression of CSTB mRNA | CTD | PMID:18930951 | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gene Ontology Annotations
Disease Annotations
|
|
Gene-Chemical Interaction Annotations
|
|
|
Gene Ontology Annotations
|
|
|
|
|
|
References - curated| 1. |
GOA_HUMAN data from the GO Consortium |
| 2. |
Online Mendelian Inheritance in Man, OMIM (TM). |
| 3. |
RGD automated import pipeline for gene-chemical interactions |
| 4. |
RGD Automated Pipelines |
References - uncurated
RGD Disease Portals| CSTB has been annotated in the following RGD Disease Portals. |
|||
![]() |
| ||
![]() |
| ||
Comparative Map Data| CSTB (Homo sapiens) |
|
|||||||||||||||||||||||||||||||||||
| Cstb (Mus musculus) |
|
|||||||||||||||||||||||||||||||||||
| Cstb (Rattus norvegicus) |
|
Position Markers| SHGC-56470 |
|
|||||||||||||||||||||||||||||||||||||||||||||
| RH103858 |
|
|||||||||||||||||||||||||||||||||||||||||||||
| G54168 |
|
|||||||||||||||||||||||||||||||||||||||||||||
| G54169 |
|
|||||||||||||||||||||||||||||||||||||||||||||
| G54170 |
|
|||||||||||||||||||||||||||||||||||||||||||||
| G54171 |
|
|||||||||||||||||||||||||||||||||||||||||||||
| G54172 |
|
|||||||||||||||||||||||||||||||||||||||||||||
| G54173 |
|
|||||||||||||||||||||||||||||||||||||||||||||
| G54174 |
|
|||||||||||||||||||||||||||||||||||||||||||||
| Cstb |
|
|||||||||||||||||||||||||||||||||||||||||||||
| SHGC-87678 |
|
QTLs in Region (Human Genome Assembly GRCh37)| The following QTLs overlap with this region. | ![]() | Full Report | ![]() | CSV | ![]() | TAB | ![]() | Printer | ![]() | Gviewer |
Nucleotide Sequences| RefSeq Acc Id: | NM_000100 | |||||||||||||||||||||||||
| RefSeq Status: | REVIEWED | |||||||||||||||||||||||||
| Type: | CODING | |||||||||||||||||||||||||
| Protein Acc Id: | NP_000091 | |||||||||||||||||||||||||
| Position: |
|
Protein Sequences
Promoters| RGD ID: | 6799389 | ||||||||||
| Promoter ID: | HG_KWN:41109 | ||||||||||
| Type: | CpG-Island | ||||||||||
| SO ACC ID: | SO:0000170 | ||||||||||
| Source: | MPROMDB | ||||||||||
| Tissues & Cell Lines: | CD4+TCell, CD4+TCell_12Hour, CD4+TCell_2Hour, HeLa_S3, K562, Lymphoblastoid, NB4 | ||||||||||
| Transcripts: | OTTHUMT00000195689, OTTHUMT00000195690 | ||||||||||
| Position: |
|
| RGD ID: | 6853214 | ||||||||||
| Promoter ID: | EP74428 | ||||||||||
| Type: | initiation region | ||||||||||
| Name: | HS_CSTB | ||||||||||
| Description: | Cystatin B (stefin B). | ||||||||||
| SO ACC ID: | SO:0000170 | ||||||||||
| Source: | EPD (Eukaryotic Promoter Database, http://epd.vital-it.ch/) | ||||||||||
| Experiment Methods: | Mammalian gene collection (MGC) full-length cDNA cloning | ||||||||||
| Position: |
|
External Database Links| Database | Acc Id | Source(s) |
| COSMIC | CSTB | COSMIC |
| Entrez Gene | 1476 | ENTREZGENE |
| Germonline | ENSG00000160213 | |
| HGNC ID | 2482 | ENTREZGENE |
| HomoloGene Group ID | 79 | ENTREZGENE |
| HPRD ID | 03091 | ENTREZGENE |
| InterPro | Prot_inh_cystat | UniProtKB/Swiss-Prot |
| Prot_inh_cystat_CS | UniProtKB/Swiss-Prot | |
| Prot_inh_stefinA | UniProtKB/Swiss-Prot | |
| KEGG Report | hsa:1476 | ENTREZGENE, UniProtKB/Swiss-Prot |
| OMIM | 254800 | OMIM |
| 601145 | OMIM | |
| Pfam | Cystatin | UniProtKB/Swiss-Prot |
| PharmGKB | PA26984 | PharmGKB |
| PRINTS | STEFINA | UniProtKB/Swiss-Prot |
| PROSITE | CYSTATIN | UniProtKB/Swiss-Prot |
| SMART | SM00043 | UniProtKB/Swiss-Prot |
| UniGene | Hs.695 | ENTREZGENE |
| UniProt | CYTB_HUMAN | UniProtKB/Swiss-Prot |
| Q76LA1_HUMAN | UniProtKB/TrEMBL |
Nomenclature History| Date | Current Symbol | Current Name | Previous Symbol | Previous Name | Description | Reference | Status |
|---|---|---|---|---|---|---|---|
| 2011-08-16 | CSTB | cystatin B (stefin B) | CSTB | cystatin B (stefin B) | Symbol and/or name change | 39860 | APPROVED |
| More on CSTB | |||
![]() |
Entrez Gene | ||
![]() |
Ensembl Gene | ||
|
|
||
![]() |
HGNC Report | ||
![]() |
NCBI Map Viewer | ||
![]() |
Vista | ||
![]() |
Vista + UCSC | ||
| RGD Object Information | |
| RGD ID: | 735434 |
| Created: | 2004-02-06 |
| Species: | Homo sapiens |
| Last Modified: | 2013-06-11 |
| Status: | ACTIVE |
© Bioinformatics Program, HMGC at the Medical College of Wisconsin
RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.




